Federal Circuit sides with Broad Institute in CRISPR clash
11-09-2018
UC, Berkeley appeals to Federal Circuit in CRISPR patent clash
18-04-2017
PTAB says Broad's CRISPR patents do not interfere with UC Berkeley's
16-02-2017
Ralwel / iStockphoto.com
The Broad Institute of Harvard and MIT has adopted three major arguments in its response to the University of California (UC), Berkeley’s appeal against a patent finding on the CRISPR technology.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Broad Institute, patent, CRISPR, PTAB, University of California, Berkeley, Patent Trial and Appeal Board, US Court of Appeals for the Federal Circuit
